CPhI China Assisting Enterprises In The Strongly Growing Chinese API Market

FOR IMMEDIATE RELEASE

As China continues to advance from a big country in pharmaceuticals to a power in pharmaceuticals, and the global economy maintains good trends, the main business income of API manufacturing in China has reached RMB 499.1 billion, growing by 14.68% year on year; and the export of APIs has reached USD 29.1 billion, growing by 13.7% year on year. Under such a background, the CPhI& P-MEC China 2019 organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and co-organized by Shanghai UBM Sinoexpo International Exhibition Co., Ltd. will be grandly held at Shanghai New International Expo Centre (SNIEC) on June 18-20, 2019. CPhIChina will assist enterprises to write a new chapter of pharmaceuticals and develop new patterns of international market with transformation and upgrading.

Exhibition scale upgraded, upstream and downstream industrial chain covered
In compliance with the industry development trends, CPhI China has been constantly exploiting and extending coverage of upstream and downstream industrial chain while deeply taking root in the pharmaceutical API industry over the 18 years. It has now included 8 segments including APIs, fine chemical and intermediate, pharmaceutical excipients, preparations, contract research, biopharmaceuticals, natural extracts, and animal health & feed, and become a professional trade exchange event in the vertical chain of the global pharmaceutical industry, which is second to none. Wherein, BioPh China will be newly upgraded into bioLIVE China in 2019, to focus on exhibition of product and technologies in genetic, antibody and biological cell engineering, to furnish biopharmaceutical companies, new drug R&D enterprises, and professionals a unique one-stop exchange platform for pharmaceutical trade, and to foster the development of the biopharmaceutical industry.

Leading innovation through an international vision, and gathering Chinese and overseas excellent exhibitor groups and visitors
The 2019 exhibition will cover all the 17 halls of SNIEC for the first time, to create the strongest lineup in its history, with the exhibition area to be expanded to 200,000m2. It is expected to gather over 3,200 Chinese and overseas excellent enterprises, and attract over 70,000 visits of Chinese and overseas professional visitors from 120 countries and regions. Over 100 high scale meetings and activities will be held on site concurrently with the exhibition, to present the latest development trends and advanced technologies of global pharmaceuticals. Famous for its high internationalization degree, CPhI& P-MEC China has attracted international exhibitor groups from South Korea and India, as well as growing numbers of international visitors from all over the world.

China Pharma Week, an unmissable annual high-end event of the pharmaceutical industry
CPhI China is an exhibition always at the forefront of the international pharmaceutical industry. The organizers will continue to launch the third edition of the 5-day “China Pharma Week” (June 17-21) in 2019, to cover themes of Leadership, Business, Networking, Recognition, Knowledge, and Innovation of the pharmaceutical industry.

For more information, please visit www.en-cphi.cn

Media Contact
Company: Shanghai Bohua International Exhibition Co., Ltd.
City, State, Country:Shanghai,China
Address: Room 608, Building A, No. 3000, Longdong Avenue, China (Shanghai) Pilot Free Trade Zone
Contact Person: Iris Feng
Tele: 020-3339 2255
Email: iris.feng@ubmsinoexpo.com
Website:  www.en-cphi.cn

###

Sponsor Ads

• Ad Space Available - Rent it Now!

Report this Page

Created on Apr 24th 2019 21:36. Viewed 147 times.

Share on APSense

Comments